Sarina Tanimoto - May 17, 2023 Form 4 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Signature
/s/ Kathleen Scott, Attorney-in-Fact
Stock symbol
SPRY
Transactions as of
May 17, 2023
Transactions value $
$0
Form type
4
Date filed
1/4/2024, 04:45 PM
Previous filing
Jan 5, 2023
Next filing
Feb 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRY Common Stock Gift $0 -1.05M -24.27% $0.00 3.28M May 17, 2023 Direct
transaction SPRY Common Stock Gift $0 +1.05M $0.00 1.05M May 17, 2023 By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006 F1
transaction SPRY Common Stock Gift $0 -1.05M -20.28% $0.00 4.13M May 17, 2023 By spouse F2
transaction SPRY Common Stock Gift $0 +1.05M +100% $0.00 2.1M May 17, 2023 By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006 F1
holding SPRY Common Stock 1.77M May 17, 2023 By Sarina Tanimoto Charitable Remainder Unitrust Dated January 7, 2020 F3
holding SPRY Common Stock 1.77M May 17, 2023 By Richard Lowenthal Charitable Remainder Unitrust Dated January 7, 2020 F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPRY Stock option (right to buy) Award $0 +300K $0.00 300K Jan 2, 2024 Common Stock 300K $5.58 Direct F5
transaction SPRY Stock option (right to buy) Award $0 +880K $0.00 880K Jan 2, 2024 Common Stock 880K $5.58 By spouse F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held in a trust for the benefit of the Reporting Person and her spouse. The Reporting Person and her spouse are trustees of the trust.
F2 The Form 4 filed November 10, 2022 inadvertently omitted 849,968 shares indirectly owned by the Reporting Person. The omitted shares are directly owned by the Reporting Person's spouse and were properly reported on his Form 4 filed November 10, 2022. The amount listed in Column 5 has been adjusted to reflect the correct holdings after giving effect to the May 17, 2023 gift transaction.
F3 The Reporting Person is trustee of the trust.
F4 The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F5 25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares will vest monthly thereafter over three years.